ElizabethMatthewsBruntMD

Pathology • Saint Louis, MO

Anatomic Pathology, Clinical Pathology

Professor, Pathology & Immunology, Washington University School of Medicine

Join to view full profile

Dr. Brunt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brunt's full profile

Already have an account?

Office
Emeritus Professor Pathology
Saint Louis, MO 63110

Education & Training

Mercy Hospital (St Louis)Residency, Pathology-Anatomic and Clinical, 1992 - 1994
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1983 - 1986
Washington University/B-JH/SLCH ConsortiumResidency, Neurological Surgery, 1982 - 1983
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1981 - 1982
University of Texas Medical Branch School of MedicineClass of 1981

Certifications & Licensure

MO State Medical License 1987 - 2026
IL State Medical License 2014 - 2017
TX State Medical License 1981 - 1998
American Board of Pathology Anatomic Pathology
American Board of Pathology Clinical Pathology

Clinical Trials

Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) Start of enrollment: 2005 Jan 01
Completed
Phase 3
Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) Start of enrollment: 2005 Sep 01
Completed
Phase 3
Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients Start of enrollment: 2005 Aug 12
Terminated
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children Start of enrollment: 2012 Jun 01
Completed
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

1590 citations
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri, Rohit Loomba, Arun J. Sanyal, Joel E. Lavine, Mark L. Van Natta
Lancet. 2015-03-14
129 citations
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial.
Lisa B. Van Wagner, Sean W.P. Koppe, Elizabeth M. Brunt, Jeanne Gottstein, Konstantina Gardikiotes
Annals of Hepatology. 2011-07-01
4418 citations
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi
Hepatology. 2018-01-01

Journal Articles

Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease
Joel E Lavine, Cynthia Behling, Jeffrey B Schwimmer, Elizabeth M Brunt, Hepatology Communications

Lectures

Surgical Pathology for the Practicing Pathologist
Harvard Medical School, Fort Myers, Florida - 3/14/2013

Press Mentions

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic SteatohepatitisApril 13th, 2020
Struggling to Find a Foothold with NAFLDMarch 1st, 2020